<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T11:39:25+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【邀请函】《治疗用生物制品病毒污染风险控制要点》新书发布会，邀您莅临</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/ZejHFPMT_xMiQ5eVPGgkYA</id>
    <link href="https://mp.weixin.qq.com/s/ZejHFPMT_xMiQ5eVPGgkYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度盘点：2020年NK细胞发展动态丨星耀研究院</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/zi9tp6-B6ki7qQJO5cxOFg</id>
    <link href="https://mp.weixin.qq.com/s/zi9tp6-B6ki7qQJO5cxOFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA三大巨头撑起约6000亿市值，国内mRNA公司一览丨医麦新观察</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/-hu0X3rNjUF4Yrg-iu6EUA</id>
    <link href="https://mp.weixin.qq.com/s/-hu0X3rNjUF4Yrg-iu6EUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊：干细胞外泌体miRNA下调促炎细胞因子，激发强大的心肌修复功能丨医麦猛爆料</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/wt0TyKzLVO47qP7u9tzVOg</id>
    <link href="https://mp.weixin.qq.com/s/wt0TyKzLVO47qP7u9tzVOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>暗流涌动的类器官领域，国内多家企业正在积极布局丨医麦新观察</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/-O3EeT2mL2QvutYpDl-Mlg</id>
    <link href="https://mp.weixin.qq.com/s/-O3EeT2mL2QvutYpDl-Mlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宋献民教授：Allo-HSCT治疗T淋巴母细胞淋巴瘤，还需解决WHO、WHEN、HOW 三个问题</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/xuK9TKQ5euw0KxSqIbavQA</id>
    <link href="https://mp.weixin.qq.com/s/xuK9TKQ5euw0KxSqIbavQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再次携手攻克实体瘤！野马生物和希望之城开启IL13Rα2-CAR T细胞临床试验丨医麦猛爆料</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/ZxTXUSEl13qbVn1yQu10kQ</id>
    <link href="https://mp.weixin.qq.com/s/ZxTXUSEl13qbVn1yQu10kQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨本周大额融资交易，艺妙神州、创胜集团、新芽基因等</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/4Q96uiXYLhycNzrNFEn0Tg</id>
    <link href="https://mp.weixin.qq.com/s/4Q96uiXYLhycNzrNFEn0Tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>属于细胞与基因治疗人的圣诞礼物来了，赶紧收好</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/_RfqzKa6A3pWqO_zvlJ9QA</id>
    <link href="https://mp.weixin.qq.com/s/_RfqzKa6A3pWqO_zvlJ9QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘澎教授：多学科协作诊治淋巴瘤大有可为，未来有三个方向值得进一步努力</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/NsUDF6BKQx762z-S392wHg</id>
    <link href="https://mp.weixin.qq.com/s/NsUDF6BKQx762z-S392wHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【延期通知】如何对细胞治疗企业进行合理估值培训班</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/tDAUv4xrHMMfXeVcTOREgw</id>
    <link href="https://mp.weixin.qq.com/s/tDAUv4xrHMMfXeVcTOREgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4亿大单背后：赛多利斯与荣昌的二十年丨医麦新观察</title>
    <updated>2020-12-24T18:50:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/4WKCXd9uxn85EGVpBuEQCw</id>
    <link href="https://mp.weixin.qq.com/s/4WKCXd9uxn85EGVpBuEQCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NIH研究团队分离出一种新冠纳米抗体，对高亲和力变体S蛋白也有阻断效果丨医麦黑科技</title>
    <updated>2020-12-24T18:50:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/aYA8PhIzcUFyXTwSM_yEGw</id>
    <link href="https://mp.weixin.qq.com/s/aYA8PhIzcUFyXTwSM_yEGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因疗法治疗耳聋都取得了哪些进展丨医麦新观察</title>
    <updated>2020-12-24T18:50:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/IBLEj9fxUGklAFFjJvF2dQ</id>
    <link href="https://mp.weixin.qq.com/s/IBLEj9fxUGklAFFjJvF2dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准BCMA​通用CAR-T联合疗法进入临床丨医麦猛爆料</title>
    <updated>2020-12-24T18:50:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/dPmgM0pqVW01G7i6t2MXNw</id>
    <link href="https://mp.weixin.qq.com/s/dPmgM0pqVW01G7i6t2MXNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张明智教授：深入研究肿瘤微环境和人体免疫功能，结合分子检测精准诊治是淋巴瘤的发展方向</title>
    <updated>2020-12-24T18:50:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/o3yKEhhbCfzUPJ03BoVGcQ</id>
    <link href="https://mp.weixin.qq.com/s/o3yKEhhbCfzUPJ03BoVGcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤免疫联合疗法是未来的主流研究方向，溶瘤病毒+CAR-T/NK细胞疗法会是实体瘤克星吗？丨医麦新观察</title>
    <updated>2020-12-24T16:16:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/1NJXls5_Py_5rxwyhhY0PA</id>
    <link href="https://mp.weixin.qq.com/s/1NJXls5_Py_5rxwyhhY0PA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>应对新冠变异病毒，BioNTech宣称6周内可出新疫苗，美国追加1亿剂丨医麦猛爆料</title>
    <updated>2020-12-24T16:16:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/jwOu959jvE1xWvyp_kHgmQ</id>
    <link href="https://mp.weixin.qq.com/s/jwOu959jvE1xWvyp_kHgmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1/CTLA-4双特异性抗体显示出治疗多种实体瘤的早期临床反应丨医麦猛爆料</title>
    <updated>2020-12-24T16:16:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/AJuh34Hf814-R5KFOgGw7Q</id>
    <link href="https://mp.weixin.qq.com/s/AJuh34Hf814-R5KFOgGw7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NK细胞工程改造新策略，针对B细胞淋巴瘤有望填补现有疗法局限性丨医麦猛爆料</title>
    <updated>2020-12-24T16:16:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tA9kyxgbyJ802iiJDXFC1Q</id>
    <link href="https://mp.weixin.qq.com/s/tA9kyxgbyJ802iiJDXFC1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>